Username Password
S&P 500: 1,351.68 Change: +0.14%

MEDIVATION INC (MDVN)

Overview
Price 68.71
Price Change Today 0.00 (0.00%)
P&P rating Rating: 3
Zacks Rank 3 - HOLD
Open Price $0.00
Previous Close $68.71
Daily Range $0.00 - $0.00
52-Week Range $14.32 - $76.65
Volume 0
chart
Medivation, Inc. is a biopharmaceutical company that acquires promising technologies in the late preclinical development phase and develops them quickly and cost-effectively. Medivation's current portfolio consists of small molecule drugs in development to treat three large, unmet medical needs Alzheimer's disease, Huntington's disease and hormone-refractory prostate cancer. The Company intends to build and maintain a portfolio of four to six development programs at all times. The Company had built a portfolio of innovative medical technologies and a team of employees and seasoned consultants with significant expertise in the identification, evaluation, acquisition, development and sale/partnering of small molecule therapeutics, biotechnology products and medical devices
Other Resources for MDVN
zacks.com
Commentary
Zacks Blog: Dendreon Gets a New CEO
February 2, 2012
Zacks Blog: Medivation/Astellas' MDV3100 Shines
February 2, 2012
Zacks Blog: Dendreon Stays Neutral
January 24, 2012
Zacks Blog: Zacks Bull and Bear of the Day Highlights: Lamar Advertising, HDFC Bank, Medivation, Pfizer and Johnson & Johnson
January 19, 2012
Zacks Blog: Pfizer-Medivation Call It Quits
January 18, 2012
Medivation, Inc. is a biopharmaceutical company that acquires promising technologies in the late preclinical development phase and develops them quickly and cost-effectively. Medivation's current portfolio consists of small molecule drugs in development to treat three large, unmet medical needs Alzheimer's disease, Huntington's disease and hormone-refractory prostate cancer. The Company intends to build and maintain a portfolio of four to six development programs at all times. The Company had built a portfolio of innovative medical technologies and a team of employees and seasoned consultants with significant expertise in the identification, evaluation, acquisition, development and sale/partnering of small molecule therapeutics, biotechnology products and medical devices
 
Brokerage Analyst Recommendations
10 Brokerage Firms Covering MDVN
 
   
Strong Buy
8
Buy
0
Hold
1
Sell
0
Strong Sell
1
Average Broker Recommendation (ABR): 1.6
 
MDVN Ratings:BUY  SELL  HOLD
MDVN Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

14 Buy
1 Sell
 
Top Buy Analysis
BUY: MDVN Rating: 3
Company: MEDIVATION INC.
Points: 237.27
Start Price: $19.70
Start Date: 09/18/2011 9:06 PM
COBeeMan
COBeeMan
P&P Score: 99.43
Recs:
Good company getting better, with a promising new drug/approach for treating prostate cancer.

Comments: 0 | Comment


Top Sell Analysis
SELL: MDVN Rating: 3
Company: MEDIVATION INC.
Points: -83.49
Start Price: $33.42
Start Date: 12/01/2009 11:18 PM
BearNekkid
BearNekkid
P&P Score: 0.48
Recs:

Comments: 0 | Comment

Blog Posts
User User Score Date Title Comments Last Comment
zantriocom
0.00 03/16/10 Zantrio.com Free Daily Stock Picks 3-16-2010 0
Neurodoc
99.60 02/03/10 M&M boys up on healthy volume today 4 02/11/10
Zacks_Analysts
0.00 02/02/12 Dendreon Gets a New CEO - Analyst Blog 0
Zacks_Analysts
0.00 02/02/12 Medivation/Astellas' MDV3100 Shines - Analyst Blog 0
Zacks_Analysts
0.00 01/24/12 Dendreon Stays Neutral - Analyst Blog 0
Zacks_Analysts
0.00 01/18/12 Pfizer-Medivation Call It Quits - Analyst Blog 0
Zacks_Analysts
0.00 11/25/11 Medivation Back to Neutral - Analyst Blog 0
Zacks_Analysts
0.00 11/23/11 Risk-Reward Balanced at Dendreon - Analyst Blog 0
Zacks_Analysts
0.00 11/14/11 Loss Increases at Medivation - Analyst Blog 0
Zacks_Analysts
0.00 11/04/11 Medivation Impresses with MDV3100 - Analyst Blog 0
Pages: [ 1 ]  2   3   4   5  >>
Commentary
BUY: MEDIVATION INC. (MDVN) Rating: 3
Start Price: $68.71
Points: -0.08
Created: 02/09/2012
This biomedical stock has some good patents. Buy

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 3
Start Price: $73.93
Points: -7.66
Created: 02/03/2012
1. Very strong upward strength. In fact, it is so strong that it may drop a bit before ascend again.
2. Institutions has been pushing the stock higher.
3. Relative strength long and short term are strong and above normal.

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 3
Start Price: $19.70
Points: +237.27
Created: 09/18/2011
Good company getting better, with a promising new drug/approach for treating prostate cancer.

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 3
Start Price: $34.34
Points: +76.08
Created: 01/23/2010
3 chances to make a significant earnings move and/or be bought

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 3
Start Price: $31.37
Points: +112.79
Created: 09/03/2008
Impressive management with great business strategy. good pipeline of new products

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 3
Start Price: $40.01
Points: +61.58
Created: 11/09/2011
fgd

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 3
Start Price: $9.08
Points: +624.47
Created: 07/06/2010

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 3
Start Price: $11.72
Points: +461.59
Created: 05/31/2010

Comments: 0 | Comment

Recs:
 
SELL: MEDIVATION INC. (MDVN) Rating: 3
Start Price: $33.42
Points: -83.49
Created: 12/01/2009

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 3
Start Price: $12.27
Points: +467.33
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
billiebear4788 89.44 BUY Six Months to a Year 02/09/2012 $68.71 $68.64
(+0.34%)
-0.10% -0.02% -0.08 view
Stock4you 21.43 BUY Week to a Month 02/03/2012 $73.93 $68.64
(+0.34%)
-7.16% +0.50% -7.66 view
Yade 99.88 BUY One to Three Years 11/09/2011 $40.01 $68.64
(+0.34%)
+71.56% +9.97% +61.58 view
COBeeMan 99.43 BUY Week to a Month 09/18/2011 $19.70 $68.64
(+0.34%)
+248.43% +11.16% +237.27 view
HardTimes 0.35 BUY One to Three Months 07/06/2010 $9.08 $68.64
(+0.34%)
+655.95% +31.48% +624.47
GreatestEver 99.59 BUY One to Three Months 05/31/2010 $11.72 $68.64
(+0.34%)
+485.67% +24.07% +461.59
justdogice 97.27 BUY Six Months to a Year 01/23/2010 $34.34 $68.64
(+0.34%)
+99.88% +23.81% +76.08 view
BearNekkid 0.48 SELL Three to Six Months 12/01/2009 $33.42 $68.64
(+0.34%)
+105.39% +21.90% -83.49
beachdude 92.53 BUY Six Months to a Year 09/03/2008 $31.37 $68.64
(+0.34%)
+118.81% +6.02% +112.79 view
Hktoozle 78.81 BUY Six Months to a Year 01/01/2008 $12.27 $68.64
(+0.34%)
+459.41% -7.92% +467.33
Pages: [ 1 ]  2  >>
Sponsored Links